BEAM (BEAM) is trading at $0.001550 down 2.70% over the past 24 hours. Its Galaxy Score is 43.1, LunarCrush's combined measure of market and social performance. Over the last 24 hours it has seen 9.2K engagements and 87 posts with 89% positive social sentiment.
AI summary: BEAM is a biotech/gene-editing-themed Layer 1 crypto token with trading activity on Binance/BNB Chain/Base, separate from BEAM Therapeutics’ public stock. BEAM’s current print near ~$0.00158 looks like a liquidity shock more than a thesis reset: the reported 168M-token MEV/Binance spot dump plus a 2B cold-wallet unlock flooded the order book and pushed price from ~$0.00224 to ~$0.00180. Social is still constructive, with biotech/Prime Medicine chatter lifting sentiment to 68% and volume up 338.97% month-over-month, but licensing concerns, macro chop, and weak fee/burn utility are capping the breakout.